Program Official
Principal Investigator
Raymond C.
Bergan
Awardee Organization
University Of Nebraska Medical Center
United States
Fiscal Year
2024
Activity Code
R01
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date
NIH RePORTER
For more information, see NIH RePORTER Project 3R01CA276846-02S1
Regulation of extracellular proteases in prostate cancer progression to a metastatic phenotype
No changes from the Parent (CA275846)
Publications
- Mukthapuram PR, Natarajan A. Domino Reactions Enable Zn-Mediated Direct Synthesis of Spiro-Fused 2-Oxindole-α-Methylene-γ-Butyrolactones/Lactams from Isatin Derivatives and 2-(Bromomethyl)acrylates. Molecules (Basel, Switzerland). 2024 Jul 30;29. (15). PMID: 39125017
- Eiken AP, Schmitz E, Drengler EM, Smith AL, Skupa SA, Mohan K, Rana S, Singh S, Mallareddy JR, Mathew G, Natarajan A, El-Gamal D. The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax. Hemato. 2024 Sep;5(3):321-339. Epub 2024 Aug 27. PMID: 39450301